Treating Amblyopia With CureSight

Status unconfirmed · Not applicable

Conditions studied: Amblyopia

In brief

Patients with visual acuity and ocular characteristics outside the Novasight FDA multi-center study are to perform the same Curesight procedures- including M\&S EVA or eETDRS patched acuity, stereo and then utilize the Curesight device 1.5 hours per day, 6 days per week over 3-6 months to determine treatment efficacy. An Eye-Tracking-Based Dichoptic Home Treatment for Amblyopia: A Multicenter Randomized Clinical Trial T. Wygnanski-Jaffe, B. J. Kushner, A. Moshkovitz, M. Belkin, O. Yehezkel and G. CureSight Pivotal Trial Ophthalmology 2023 Vol. 130 Issue 3 Pages 274-285

Key facts

Study ID

NCT06165705

Run by

Alaska Blind Child Discovery

People needed

20

Starts

2023-03-01

Expected to finish

2025-12-31

Last updated by the study team

2024-08-26

Who can join

Age: 2 and older, up to 20. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• amblyopia

You may not qualify if…

• lack of brain and eye capacity for improved vision lack of home WiFi

Where it is running

• Alaska Blind Child Discovery — Anchorage, Alaska, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.